Amlodipine/valsartan

Source: Wikipedia, the free encyclopedia.

Amlodipine/valsartan
Angiotensin II receptor antagonist
Clinical data
Trade namesExforge
AHFS/Drugs.comProfessional Drug Facts
License data
Pregnancy
category
Routes of
administration
By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
KEGG
CompTox Dashboard (EPA)
  (verify)

Amlodipine/valsartan, sold under the brand name Exforge among others, is a

angiotensin II receptor antagonist.[3] This combination is usually well tolerated and effective for the reduction of blood pressure.[4]

The combination was approved for medical use in the United States in June 2007.[5]

The combination is also available with included hydrochlorothiazide (Exforge HCT), for people who need a three-drug regimen to manage their blood pressure.[6][7] It was approved for medical use in the United States in April 2009.[8]

References

  1. ^ "Amlodipine / valsartan (Exforge) Use During Pregnancy". Drugs.com. 11 July 2019. Retrieved 13 February 2020.
  2. ^ "Exforge- amlodipine besylate and valsartan tablet, film coated". DailyMed. 12 June 2019. Retrieved 12 February 2020.
  3. ^ "Valsartan Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019.
  4. S2CID 25814898
    .
  5. ^ "Drug Approval Package: Exforge (amlodipine and valsartan) NDA #021990". U.S. Food and Drug Administration (FDA). 3 October 2008. Retrieved 19 September 2021.
  6. ^ "Exforge HCT- amlodipine valsartan and hydrochlorothiazide tablet, film coated". DailyMed. Retrieved 12 February 2020.
  7. ^ "Amlodipine, Valsartan, and Hydrochlorothiazide". Drugs.com.
  8. ^ "Drug Approval Package: Exforge HCT (Amlodipine, Valsartan, Hydrochlorothiazide) Tablets NDA #022314". U.S. Food and Drug Administration (FDA). 2 September 2009. Retrieved 19 September 2021.

External links